Peter A. Todd

4.6k total citations · 1 hit paper
40 papers, 3.7k citations indexed

About

Peter A. Todd is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Medicine. According to data from OpenAlex, Peter A. Todd has authored 40 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Medicine. Recurrent topics in Peter A. Todd's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Peter A. Todd is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Peter A. Todd collaborates with scholars based in France. Peter A. Todd's co-authors include Eugene M. Sorkin, Paul Benfield, Karen L. Goa, Rex N. Brogden, J. Paul Monk, Stephen P. Clissold, Deborah M. Campoli-Richards, R.C. Heel, Allan H. Price and Alan Ward and has published in prestigious journals such as Drugs, The Medical Journal of Australia and PubMed.

In The Last Decade

Peter A. Todd

39 papers receiving 3.3k citations

Hit Papers

Ciprofloxacin 1988 2026 2000 2013 1988 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Todd France 28 1.0k 629 605 498 347 40 3.7k
Georges Houin France 35 1.0k 1.0× 341 0.5× 738 1.2× 402 0.8× 537 1.5× 205 4.3k
Avraham Yacobi United States 32 1.2k 1.1× 331 0.5× 1.3k 2.1× 255 0.5× 289 0.8× 128 6.0k
Peter G. Welling United States 36 1.3k 1.2× 200 0.3× 501 0.8× 224 0.4× 422 1.2× 123 3.9k
Milo Gibaldi United States 39 899 0.9× 290 0.5× 843 1.4× 312 0.6× 178 0.5× 170 5.4k
Dion R. Brocks Canada 37 830 0.8× 270 0.4× 1.0k 1.7× 537 1.1× 210 0.6× 139 4.3k
Julia A. Balfour New Zealand 38 821 0.8× 207 0.3× 1.1k 1.9× 361 0.7× 877 2.5× 74 4.9k
Lynda R. Wiseman New Zealand 33 437 0.4× 255 0.4× 675 1.1× 456 0.9× 316 0.9× 63 3.1k
Yusuke Tanigawara Japan 40 1.4k 1.3× 266 0.4× 2.1k 3.5× 848 1.7× 735 2.1× 177 8.8k
Roger K. Verbeeck Belgium 36 1.2k 1.2× 246 0.4× 647 1.1× 393 0.8× 569 1.6× 156 4.7k
Uwe Fuhr Germany 47 1.2k 1.2× 214 0.3× 1.3k 2.2× 412 0.8× 468 1.3× 199 6.9k

Countries citing papers authored by Peter A. Todd

Since Specialization
Citations

This map shows the geographic impact of Peter A. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Todd more than expected).

Fields of papers citing papers by Peter A. Todd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Todd. The network helps show where Peter A. Todd may publish in the future.

Co-authorship network of co-authors of Peter A. Todd

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Todd. A scholar is included among the top collaborators of Peter A. Todd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Todd. Peter A. Todd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todd, Peter A., et al.. (1995). Fleroxacin. Drugs. 49(5). 794–850. 20 indexed citations
2.
Todd, Peter A. & Diana Faulds. (1992). Felodipine. Drugs. 44(2). 251–277. 69 indexed citations
3.
Todd, Peter A. & Andrew Fitton. (1991). Gallium Nitrate. Drugs. 42(2). 261–273. 43 indexed citations
4.
Todd, Peter A. & Diana Faulds. (1991). Ofloxacin. Drugs. 42(5). 825–876. 80 indexed citations
5.
Todd, Peter A. & Stephen P. Clissold. (1991). Tenoxicam. Drugs. 41(4). 625–646. 61 indexed citations
6.
Todd, Peter A., Karen L. Goa, & Heather D. Langtry. (1990). Transdermal Nitroglycerin (Glyceryl Trinitrate). Drugs. 40(6). 880–902. 23 indexed citations
7.
Todd, Peter A. & Karen L. Goa. (1990). Simvastatin. Drugs. 40(4). 583–607. 183 indexed citations
8.
Todd, Peter A. & Stephen P. Clissold. (1990). Naproxen A Reappraisal of its Pharmacology, and Therapeutic Use in Rheumatic Diseases and Pain States. Drugs. 40(1). 91–137. 175 indexed citations
9.
Todd, Peter A. & Paul Benfield. (1990). Ramipril. Drugs. 39(1). 110–135. 66 indexed citations
10.
Todd, Peter A. & Rex N. Brogden. (1990). Cefotaxime. Drugs. 40(4). 608–651. 36 indexed citations
11.
Todd, Peter A. & Karen L. Goa. (1989). Enalapril. Drugs. 37(2). 141–161. 15 indexed citations
12.
Todd, Peter A. & Paul Benfield. (1989). Flunarizine. Drugs. 38(4). 481–499. 68 indexed citations
13.
Todd, Peter A. & Rex N. Brogden. (1989). Muromonab CD3. Drugs. 37(6). 871–899. 90 indexed citations
14.
Collen, D, Henri Roger Lijnen, Peter A. Todd, & Karen L. Goa. (1989). Tissue-Type Plasminogen Activator. Drugs. 38(3). 346–388. 120 indexed citations
15.
Todd, Peter A. & Alan C. Ward. (1988). Gemfibrozil. Drugs. 36(3). 314–339. 128 indexed citations
16.
Todd, Peter A., et al.. (1988). Ibopamine. Drugs. 36(1). 11–31. 37 indexed citations
17.
Todd, Peter A., et al.. (1988). Lisinopril. Drugs. 35(6). 646–669. 107 indexed citations
18.
Brogden, Rex N. & Peter A. Todd. (1987). Encainide. Drugs. 34(5). 519–538. 4 indexed citations
19.
Gonzalez, John P. & Peter A. Todd. (1987). Tenoxicam. Drugs. 34(3). 289–310. 75 indexed citations
20.
Todd, Peter A., et al.. (1964). CEREBRO‐SPINAL FLUID AND SERUM PROTEIN PROFILES IN DETERIORATED EPILEPTICS, MENTAL DEFECTIVES WITH EPILEPSY, AND SCHIZOPHRENICS. The Medical Journal of Australia. 2(19). 751–753. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026